Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-08-29

FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a Gabapentin supplemental application from Granules Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)